Risedronate Sodium
- Product NDC
- 16714-870
- 11-digit product format
- 167140870
- Labeler code
- 16714
- Product ID
- 16714-870_7b9bda88-4331-4285-b897-1945948ea8b6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Risedronate Sodium
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- NorthStar RxLLC
- Application
- ANDA203925
- Marketing category
- ANDA
- Marketing start
- 2019-08-14
- Marketing end
- 0000-00-00
- Substance
- RISEDRONATE SODIUM
- Active strength
- 35 mg/1
- Pharmacologic classes
- Bisphosphonate [EPC],Diphosphonates [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-870-02 | 16714087002 | 1 DOSE PACK in 1 CARTON (16714-870-02) > 4 TABLET, DELAYED RELEASE in 1 DOSE PACK (16714-870-01) | 1 dose pack | 2019-08-14 | 0000-00-00 | No | No | Current |